Respiratory Distress Syndrome in Premature Infant Clinical Trial
Official title:
Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.
For therapy of respiratory distress syndrome (RDS) in premature babies, there are several
established options. An important therapeutic aspect is the tracheal administration of
exogenous surfactant into the child's lung.
In the recent years, several methods have been developed. The methods differ in the selected
ventilation mode (intubation with mechanical ventilation vs. Continous Positive Airway
Pressure (CPAP)-supported spontaneous breathing) and in the way in which the application of
surfactant is technically conducted (via endotracheal tube, endotracheal catheter or
nebulization).
In selection of ventilation technique, there is an upcoming trend towards less invasive
respiratory support via CPAP. While this may increase the rate of complications on the one
side (i.e. pneumothorax), it shows much lower oxygen demand and a shorter need for mechanical
ventilation on the other side.
In the selection of the administration technique, different methods were repeatedly developed
to adapt the surfactant administration to the CPAP therapy. In this study, a newly developed
and in the European Community now certified (CE-Mark) application aid (Neofact) will be
tested for the first time on preterm infants, to verify the feasibility.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04016246 -
Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.
|
Phase 3 | |
Enrolling by invitation |
NCT04118400 -
Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
|
||
Completed |
NCT01941745 -
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT04019106 -
Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04862377 -
Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
|
Phase 3 | |
Not yet recruiting |
NCT05791331 -
REspiratory MEchanics for Delivering Individualised Exogenous Surfactant
|
N/A | |
Not yet recruiting |
NCT05609877 -
The NONA-LISA Trial
|
N/A | |
Recruiting |
NCT04326270 -
Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs
|
N/A | |
Active, not recruiting |
NCT03969992 -
A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
|
Phase 2 | |
Completed |
NCT03700606 -
Physiological Changes With High-Flow Nasal Cannula
|
N/A | |
Recruiting |
NCT04359134 -
Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
|
||
Not yet recruiting |
NCT06229821 -
Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants
|
N/A | |
Recruiting |
NCT05446389 -
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
|
N/A | |
Withdrawn |
NCT04914715 -
nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome
|
N/A | |
Recruiting |
NCT03825835 -
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
|
N/A | |
Recruiting |
NCT03562182 -
Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
|
||
Completed |
NCT05031650 -
Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room
|
N/A | |
Completed |
NCT03306524 -
The Role of Circuit Flow During Mechanical Ventilation of Neonates
|
N/A | |
Completed |
NCT01473264 -
Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
|
Phase 1/Phase 2 | |
Completed |
NCT03548324 -
Enteral Nutrition Tolerance And REspiratory Support (ENTARES)
|
N/A |